Giving patients a financial incentive for completing a fecal immunochemical test did not increase completion rates, according to research published in JAMA Network Open.
GI & Endoscopy
Here are the five most-read articles on Becker's ASC Review for the week of March 21 -27:
Sonora Quest Laboratories made its blood-based colorectal cancer test BeScreened-CRC available to the public, AZ Central reports.
Zachary, La.-based Lane Gastroenterology celebrated its ribbon cutting March 19, The Advocate reports.
Here are three updates on gastroenterology and industry-relevant companies to know from the past week:
Shivakumar Vignesh, MD, is the gastroenterology and hepatology division chief at SUNY Downstate Medical Center.
Columbus-based Ohio Gastroenterology Group is moving into a 42,000-square-foot medical office building and opening an endoscopy center, Columbus Business First reports.
Black Book ranked a number of Modernizing Medicine's EHRs No. 1 on its Physician Practice & Ambulatory Solutions top EHR list.
A study published in Cancer examined early-onset colorectal cancer finding unique subgroups among CRC patients, Medscape reports.
Although Exact Sciences' Cologuard completed its 2 millionth test, the multitarget stool DNA test remains a topic of contention in the gastroenterology space.
